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Objectives: The role of bypass to the distal arteries for patients with Buerger's disease (thromboangiitis or TAO) remains 
controversial because of the high incidence of graft failure. We retrospectively reviewed the results of 71 bypasses to evaluate 
their efficacy. 
Materials and methods: We performed 71 autogenous vein bypasses in 61 patients with TAO. Of the patients, 97% were 
heavy smokers. The indications for surgery were claudication in 41%, and ischaemic ulcer or gangrene in 59%. Of the 
bypasses 85% were to the crural arteries or to the arteries below the ankle. The grafts used were 53 single saphenous veins, 
and 18 venovenous composite grafts. 
Results: There were 38 graft failures, the main causes including anastomosis to a diseased artery, disease progression 
(which occurred in smokers after surgery), and vein graft stenosis. 0f38, 10 were restored to patency by revision surgery. 
Primary and secondary patency rates were 48.8% and 62.5% at 5 years, and 43.0% and 56.3% at 10 years, respectively. 
The patency rates of the postoperative non-smoking group was significantly higher than that of the smoking roup (66.8% 
vs. 34.7%, p < 0.05). Thirty-six patients (59%) had successful revascularisation and returned to full-time work. However, 
of 28 with secondary failure, 11 underwent amputation, while 14 had persistent disabling claudication. 
Conclusion: Bypass to the distal arteries is an effective treatment for TAO patients, and the long-term patency is quite 
satisfactory as long as patients top smoking. 
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Introduction 
The most common initial symptom of Buerger's 
disease (thromboangiitis obliterans or TAO) is a 
painful ischaemic ulcer on the one of the toes, and the 
disease progression is considered to be closely related 
to cigarette smoking. The ulcers are commonly accom- 
panied by severe pain and usually prove intractable to 
medical therapN even after the cessation of smoking. 
Patients often need opiate analgesia to obtain pain 
relief and sufficient sleep. Thus, the only alternatives 
for these patients are bypass urgery or amputation. 
Bypasses to the distal arteries for TAO patients with 
lower limb iscahemia were aggressively performed in 
Japan until 15 years ago. Although the number of 
cases at each institute was too small to provide 
sufficient statistical analyses of the results, bypass 
surgery for TAO is now less common because of the 
technical difficulties involved and the poor results 
achieved. 1'2 Hence the role of bypass urgery for TAO 
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patients remains controversial and unclear, 3'4 and 
significant evaluation for long-term results has yet to 
be reported. The objectives of this paper are to assess 
the efficacy and durability of bypass for patients with 
TAO and the factors influencing the long-term 
results. 
Patients and Methods 
Following the guidelines for the diagnosis of TAO 
reported by the Buerger's Disease Research Commit- 
tee of the Ministry of Health and Welfare of Japan in 
1973 (which was partially revised in 1990), 5"6 the 
diagnosis of TAO in the majority of patients was made 
when those patients exhibiting infrainguinal arterial 
occlusion with angiographic features characteristic of
TAO (Fig. 1) and no evidence of atherosclerotic lesions 
or other vascular diseases satisfied the following 
criteria: (1) a history of smoking; (2) onset before 50 
years of age; and (3) an absence of arteriosclerotic r sk 
factors such as diabetes, hyperlipidaemia, or hyper- 
tension. Even if the onset was after the age of 50 years, 
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when patients had typical arteriographic findings of 
TAO without any evidence of atherosclerotic lesions, 
we included them in the TAO group. Coexistent upper 
limb involvement and/or phlebitis migrans were 
corroborative, but not essential, signs for the diagnosis 
of TAO. 
Between April 1977 and July 1995, surgical treat- 
ment was performed on 84 consecutive patients (98 
limbs) with TAO. Of the 84, 23 underwent sym- 
pathectomy alone, while the remaining 61 patients 
underwent 71 autogenous vein bypasses to the infra- 
geniculate arteries. All bypasses were performed after 
obtaining apromise from each patient o quit smoking 
postoperatively. The ages at onset and at the time of 
bypass urgery ranged from 22 to 61 years (mean age: 
39.8 + 4.8) and 24 to 66 years (mean age: 42.8 + 4.4), 
respectively. The mean duration of symptoms was 34 
months. The 61 patients included 52 men and nine 
women; 97% were heavy smokers (more than 20 
cigarettes a day), and 18% had coexistent upper limb 
involvement, while 36% of all patients had a history of 
Fig. 1. Arteriogram of a 41-year-old man with TAO, showing typical 
angiographic findings of TAO. The superficial femoral artery is 
disease flee, and occluded abruptly at the Hunter's canal. The 
popliteal and crural arteries have segmental occlusions. 
Table 1. Demographics of TAO patients who underwent bypass 
surgery. 
61 cases/711imbs 
Mean age 
at onset 
at bypass urgery 
Duration of symptoms 
Gender 
Male 52 (85%) 
Female 9 (15%) 
History 
Smokers 59 (97%) 
Non-smokers 2* (3%) 
Upper extremity involvement 11 (18%) 
Bypass surgery 4 (7%) 
Sympathectomy 14 (20%) 
Contralateral major amputation 4 (7%) 
39.8+4.8 (22,-61) years 
42.8+4.4 (24-66) years 
34.0_+16.0 (2--120) months 
*=probable passive female smokers. 
bypass surger~ sympathectomy, or contralateral 
major amputation (Table 1). Ten patients had onset 
after 50 years of age, including a 61-year-old male, but 
all patients atisfied the other criteria. Although there 
were two female patients who were actually non- 
smokers, they had a history of passive inhalation of 
heavy amounts of secondary smoke in their work- 
place. Indications for surgery were claudication in 
41%, small single ischaemic ulcer of the toes in 22%, 
and foot or limb salvage in 37%. 
Of the 71 bypasses, 75% were to the crural arteries, 
17% were to the arteries below the ankle, and only 8% 
were to the popliteal artery below the knee. The 
superficial femoral artery or infrageniculate arteries 
were selected as the proximal anastomotic site in 75% 
of bypasses. The grafts used were 53 single saphenous 
veins, which included 38 reversed, six non-reversed, 
and nine in situ saphenous veins, and 18 venovenous 
composite grafts. Seven arm veins were used for 
composite grafts (Table 2). Sympathectomy in combi- 
nation with bypass surgery was performed on 38 
patients who had a history of recurrent toe ulceration 
or multiple occlusive lesions in the arteries below the 
Table 2. Types of veins used for bypass. 
No. of grafts 
Long saphenous veins 53 
Reversed 38 
Non-reversed 6 
In situ 9 
Venovenous composite grafts 18 
Two 13 
Three or more 5 
Arm vein 7 
Accessory saphenous vein 2 
Total 71 
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ankle. The graft should be anastomosed to a normal 
arterial segment, which is shown by a clear outline on 
the preoperative arteriogram and also confirmed by 
the operative finding of an artery without adhesions. 
The wall of the distal artery is very thin, and 
dissection of arterial segments inevitably provokes 
severe spasm (Fig. 2), leading to a predisposition to 
technical error. It is important o wait until spasm is 
relieved before starting the anastomosis by applying a 
moist pad soaked with warm 2% xylocaine to the 
wound. While waiting, it is usually possible to 
complete the dissection of the artery for the proximal 
anastomosis and to fashion the tunnel for the graft. 
The distal anastomosis was performed mainly with 
three interrupted 8-0 polypropylene sutures for the toe 
of the anastomosis, and then with continuous lateral 
sutures. In the cases of bypass to the medial plantar 
arterN 9-0 nylon sutures were used. A satisfactory 
technical result was confirmed by intraoperative 
arteriography. Blood flow through the graft was also 
measured by electromagnetic flow probe on comple- 
tion of the procedure. 
All of the patients were followed up monthly for the 
first 3 months, then at 3 month intervals for 2 years, 
and every 6 months thereafter. Graft function was 
assessed by the ankle brachial pressure index (ABI) 
and analysis of the Doppler ultrasonography spec- 
trum. When the reduction of wave height along with 
disappearance of the reverse-flow component in Dop- 
pler analysis or the ABI decreased by 0.2 or more, the 
follow-up interval was shortened to 2 weeks in order 
to detect he early onset of vein graft abnormality. To 
obtain objective evidence of non-smoking after sur- 
get!6 the carboxy-haemoglobin level in the venous 
blood was monitored in all patients. Low-dose aspirin 
(81 mg/day) or trapidil 7 (300 mg/daN Rocornal ®, 
Mochida Co., Ltd., Tokyo), an antagonist to platelet- 
derived growth factor, were administered to 51 
patients (59 grafts). Of the 51, 31 (35 grafts) were also 
given warfarin concomitantly. All medical therapy 
was discontinued after 2 years, if the graft was 
functioning well. 
All data is presented as the mean _+ 2 S.E. Statistical 
analyses were performed using the Student's t-test, 
the Chi-square test or the one-way ANOVA. The 
patency rates were determined in accordance with the 
Ad Hoc Committee on Reporting Standards, the 
Society for Vascular Surgery/North American Chap- 
(a) (b) 
Fig. 2. Arteriograms of a 38-year-old man who underwent femoroposterior t bial bypass. (a) complesion arteriogram showing severe arterial 
spasm at the anastomosis; (b)arteriogram 3 weeks after surgery showing no spasm. 
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ter, International Society for Cardiovascular Surger}~ 
and compared with use of the log-rank test. 
Results 
The mean follow-up period was 62.6 months. There 
were 14 early failures, the causes including poor 
quality vein, inadequate technique for anastomosis or 
tunneling, and anastomosis to a diseased arterial 
segment. Of 24 late failures, the main causes were 
disease progression, which commonly occurred in 
continued smokers, and vein graft stenosis due to 
intimal hyperplasia (Table 3). All causes were con- 
firmed by arteriography and/or  intraoperative find- 
ings at revision surgery. Of the total of 38 graft 
failures, 10 were restored to patency by partial graft 
replacement for a poor quality vein segment or jump 
bypass grafting for a diseased arterial segment. The 
primary, assisted primary, and secondary cumulative 
patency rates for the 71 grafts were 48.8%, 58.0%, 
62.5% at 5 years, and 43.0%, 52.1%, 56.3% at 10 years, 
respectively (Fig. 3). There was no significant differ- 
ence between them. Of the 28 limbs with secondary 
graft failures, three had a successful redo bypass, 
whereas 11 underwent amputation (8 minor, 3 major) 
and the remaining 14 had persistent disabling claudi- 
cation which affected their ability to work. Of these 14 
claudicators, five developed atrophy of the foot or calf 
as a result of long-standing ischaemia. The longest 
duration of follow-up in 36 patients (59%) with patent 
grafts was 16 years, and all of them returned to full- 
time work. 
The influence of the following variables on graft 
patency was examined: age at onset and surgery; 
gender; duration of morbidity; indication for surgery; 
sympathectomy; number of diseased segments; site of 
the distal anastomosis; vein quality; graft blood flow; 
and smoking after surgery. Of the 71 bypasses, when 
Table 3. Causes  o f  p r imary  graft  fa i lure.  
No. of grafts 
Early failures 14 (5) 
Poor quality vein 5 (2) 
Inadequate t chnique for anastomosis 4 (1") 
Inadequate tunneling 1 (1) 
Anastomosis to diseased artery 2 (1") 
Arterial spasm during postoperative angiography 1 
Vein graft stenosis due to intimal hyperplasia 1 
Late failures (>3 months) 24 (7) 
Disease progression in smokers after surgery 8* 
in non-smokers after surgery 1 (1) 
Vein graft stenosis due to intimal hyperplasia 10 (4) 
Atherosclerosis 2 (1) 
Vein graft aneurysm 1 (1) 
Completion with collateral flow 1 
Undetermined 1 
Total 38 (12) 
( )---successful revision; (*)=late failure after evision; *---including one 
female passive smoker. 
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Fig. 3. The primary, the assisted primary, and the secondary cumulative patency rates for 71 autogenous vein grafts, showing no significant 
difference between them. (@) secondary patency rate; ([2) assisted primary patency rate; (©) primary patency rate. 
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63 (exclusive of 8 secondary failures within 1 month 
after surgery) were divided into groups of non- 
smokers and smokers after surgery, the 5-year life- 
table patency rates for both groups were 66.8% and 
34.7%, respectively (p < 0.05) (Fig. 4). The mean graft 
blood flow rates at the completion of bypass surgery 
were significantly associated with patency. Poor vein 
graft quality was also significant risk factors for early 
graft failure, but none of the other variables appeared 
to have a significant influence on the patency of grafts 
(Table 4). There was no evidence that anticoagulant 
and antiplatelet therapies were effective in preventing 
late graft failure. 
Discussion 
The guidelines for the diagnosis of TAO which we 
have employed are widely accepted in Japan. Shio- 
noya 8 described the clinical criteria, which do not 
include angiographic findings, for the diagnosis of 
TAO as follows: (1) smoking history; (2) onset before 
50 years of age; (3) infrapopliteal arterial occlusive 
lesions; (4) either upper limb involvement or phlebitis 
migrans; and (5) absence of atherosclerotic risk factors 
other than smoking. Our series included 10 patients 
with the onset in their 50s and two female non- 
smokers. However, Shionoya also found that TAO 
may affect smokers in their 50s, with the possibility of 
TAO in non-smokers who are continuously exposed to 
environmental tobacco smoke. Olin et al. 9 reported 
that his series included 23% women and 7% patients 
with the onset after 60 years. Hence, we considered 
that these 12 patients were unequivocal cases of 
TAO. 
The indications of the primary bypass surgery were 
disabling claudication in the calf as well as limb or 
foot salvage. Patients with ulcers are usually initially 
treated medically or by lumbar sympathectomy, and 
some of them may well respond to such therapy. 
Fiessinger and Schafer 1° reported iloprost, a chem- 
ically stable prostacyclin analogue, was effective for 
ischaemic ulcers of TAO patients. However, since the 
arterial occlusion is commonly multisegmental, 11 the 
ulcer goes through repeated cycles of healing and 
recurrence, m Even when the ulcers can be healed 
conservatively, this requires several months of treat- 
ment and disabling claudication remains. Since TAO 
patients are generally relatively young and active, 
their claudication often affects their ability to work. 
The need to repeatedly take time off work for 
conservative therapy will often compel a patient to 
cease working or at least to change the type of work 
performed. There is no reliable medical therapy for 
claudication, 13whereas the results of a prospective 
randomised study indicated that, compared with 
physical training, surgical reconstruction was a supe- 
rior treatment modality for claudicators. 14Moreover, 
as Regensteiner t at. 15 reported, we observed that one- 
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Fig. 4. The cumulative patency curves comparing groups of non-smokers and smokers after surgery (exclusive ofsecondary early failures), 
demonstrating a significant difference between them (p < 0.05). Interrupted line indicates an s.E. greater than 10%. (Q) non-smoking after 
surgery; (©) smoking after surgery. 
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third of claudicators who had no choice but medical 
therapy due to graft failure developed atrophy of the 
ischaemic foot or calf. These results justify the aggres- 
sive bypass surgery in TAO patients with lower limb 
ischaemia. 
Our present results for TAO patients were not as 
good as those for patients with arterioslerosis obliter- 
ans (ASO). This is thought o be due to the technical 
difficulties in grafting and the disease progression 
caused by continued smoking. 16 Poor quality veins 
due to phlebitis were also an important influencing 
factor. To improve the early patency rate, evaluation of 
the angiographic and intraoperative features of the 
diseased arterial segments, exquisite surgical tech- 
nique, and the use of disease-free vein grafts are all 
essential. The technical difficulties we encountered 
consisted of severe arterial spasm after dissection and 
the existence of multiple segmental TAO lesions. The 
anastomosis hould be performed to the healthiest 
vessel segment available whenever possible. A recan- 
alised or diseased arterial segment develops periarter- 
ial adhesions and oedematous intimal thickening. To 
avoid anastomosis to a diseased arterial segment, a 
segment with sharp clear margins on the arteriogram 
611 should be chosen," even if it is more distal, as 
Table 4. Factors affecting primary vein graft failure in TAO 
patients. 
Primary failures 
Patent 
grafts Early Late 
Characteristics (n=33) (n=14) (n=24) p-value 
Age* 
Onset 42.4+3.6 37.9+5.0 37.0+3.2 0.0880 
Surgery 44.3_+3.6 41.4+5.0 41.6+3.6 0.4798 
Gender 
Male (%) 29 (88%) 10 (71%) 22 (92%) 0.2030 
Duration of symptoms* 
(months) 24.6_+9.8 42.0+17.4 41.8+16.4 0.1042 
Indication for surgery 
Claudication 17 (52%) 5 (36%) 7 (29%) 
Limb or foot 0.2163 
salvage 16 (49%) 9 (64%) 17(71%) 
Sympathectomy 
Yes 20 (61%) 10 (71%) 22 (92%) 
No 13 (39%) 4 (29%) 2 (8%) 0"0322# 
No. of diseased segments 
1 8 (24%) 2 (14%) 4 (17%) 
2ormore 25 (76%) 12 (86%) 20 (83%) 0.6607 
Site of distal anastomosis 
Popliteal rtery 1 (3%) 1 (7%) 4 (17%) 
Crttral arteries 28 (85%) 9 (64%) 16 (67%) 0.2368 
Below the ankle 4 (12%) 4 (29%) 4 (17%) 
Quality of vein graft 
Good or fair 29 (88%) 7 (50%) 20 (83%) 
Poor 4 (12%) 7 (50%) 4 (17%) 0.0117 
Graft blood flow* 103.3+_20.8 62.3+18.8 3.8_+17.4 0.0483 
*=One-way ANOVA; #=Sympathectomy adversely affected patency. 
anastomosis to a diseased artery is technically more 
demanding and less likely to be successful. 
The poor quality of veins in TAO patients tends to 
predispose the early graft failure. This is caused by the 
migrating phlebitis, which is confirmed by skin 
pigmentation along the veins, a thickened and whitish 
appearance at the time of initial exploration, and poor 
distensibility on preparation. When the ipsilateral 
veins show such findings, aggressive use of the 
contralateral saphenous vein or arm veins is strongly 
recommended to avoid graft failure. Vein graft sten- 
osis due to progressive intimal hyperplasia, which is 
common in bypass grafting on ASO patients, is the 
main cause of failure in bypass, and frequently occurs 
in poor quality veins. 1738 
To prevent he late graft failures due to the disease 
progression, cessation of smoking by the patient 
himself is an essential requirement. 3'4 Of nine patients 
with graft failure due to disease progression, eight 
were smokers who continued smoking after surgery, 
whereas the disease progression was rarely seen in 
non-smokers, demonstrating a long-term patency 
comparable to that of ASO. Hence, the most important 
part of postoperative surveillance is to check for 
smoking as well as vein graft stenosis. Therefore, 
bypass surgery is not indicated in patients who cannot 
stop smoking and in whom careful surveillance is 
difficult. Redo bypass for smokers after the primary 
bypass surgery is not recommended for the same 
reason. In these patients, amputation of the foot or the 
lower leg may eventually be required. 
In conclusion, patients with TAO are relatively 
young and active, and disabling claudication often 
affects their ability to work. Medical therapy is of little 
help in significantly relieving their symptoms whereas 
the long-term results obtained with infrainguinal 
bypasses were durable and provided excellent results 
as long as patients quit smoking after surgery. Thus 
we conclude that it is reasonable to aggressively 
pursue the use of bypass surgery in patients who can 
stop smoking. 
References 
1 SHIONOYA S, BAN I, NAKATA Yet al. Vascular reconstruction in 
Buerger's disease. Br ] Surg 1976; 63" 841-846. 
2 SHIONOYA S. Surgical treatment. In: Shionoya S, ed. Buerger's 
Disease. Pathology, diagnosis and treatment. Nagoya: University of 
Nagoya Press, 1990: 212-241. 
3 SHIONOYA S. Buerger's disease: diagnosis and management. 
Cardiovasc Surg 1993; 1" 207-214. 
4 SAYIN A, BOZKURT AK, TUZUN H, VURAL FS, ERDOG G, OZER M. 
Surgical treatment of Buerger's disease: experience with 216 
patients. Cardiovasc Surg 1993; 1" 377-380. 
Eur I Vasc Endovasc Surg Vol 13, February 1997 
192 T. Sasajima et al. 
5 TANABE T. Comparative studies on criteria for classification and 
diagnosis of vasculitis yndromes. In Tanabe T, ed. Intractable 
vaseulitis yndromes. Sapporo: Hokkaido University Press, 1993: 
3-14. 
6 SASAJIMA T, KuBo Y/IZUMI Y, INABA M, GOH K. Plantar or dorsalis 
pedis artery bypass in Buerger's disease. Ann Vasc Surg 1994; 8: 
248-257. 
70HNISHI t-t, YAMAGUCHI K~ SHIMADA Set al. A new approach to the 
treatment of atherosclerosis and trapidil as an antagonist to 
platelet-derived growth factor. Life Sciences 1981; 28: 1641-1646. 
8 SHIONOYA S. Diagnosis. In Shionoya S, ed. Buerger's Disease. 
Pathology, diagnosis and treatment. Nagoya: University of Nagoya 
Press, 1990: 189-198. 
9 OLIN JW, YOUNG JR, GRAOR RA, RUSCHHAUPT WE BARTHOLOMEW 
JR. The changing clinical spectrum of thromboangiitis obliterans 
(Buerger's disease). Circulation 1990; 82 (Suppl. 5): 4.3--8. 
10 FIESSINGER JN, SCHAFER M. Trial of iloprost versus aspirin 
treatment for critical imb ischaemia of thromboangiitis obliter- 
ans. The TAO study. Lancet 1990; 335: 555-557. 
11 HAGEN B, LOHSE S. Clinical and radiologic aspects of Buerger's 
disease. Cardiovasc Intervent RadioI 1984; 7: 283-293. 
12 OHTA T, SHIONOYA S. Fate of the ischemic limb in Bueger's 
disease. Br J Surg 1988; 75: 259-262. 
13 CRIADO E, RAMADAN F/ KEAGY BA, JOHNSON G, JR. Intermittent 
claudication. SGO 1991; 173- 163-170. 
14 LUNDGREN F, DAHLLOF AG, LLrNDHOLM K, SCHERSTEN % VOLK- 
MANN R. Intermittent claudication - -  Surgical reconstruction or
physical training? Ann Surg 1989; 209: 346-355. 
15 REGENSTEINER JG, WOLFEL EE, BRASS EP et al. Chronic changes in 
skeletal muscle histology and function in peripheral arterial 
disease. Circulation 1993; 87" 413-421. 
16 PAPA M, BAss A, ADAR R, HALPERIN Z. et al. Autoimmune 
mechanisms in thromboangiitis obliterans (Buerger's disease): 
the role of tabacco antigen and the major histocompatibility 
complex. Surgery 1992; 111: 527-531. 
17 SALDEN JG, GILMOUR JL. Vein graft stenosis: Characteristics and 
effect of treatment. Am J Surg 1981; 141: 549-553. 
18 SASAJIMA T, KUBO Y, KOKUBO M. et al. A comparison of reversed 
vein and in situ saphenous vein grafts for infragenicular bypass: 
Experience of two surgeons. Cardiovasc Surg 1993; 1: 38-43. 
Accepted 23 June 1996 
Eur J Vasc Endovasc Surg Vol 13, February 1997 
